Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15-23years

被引:11
|
作者
Baudu A. [1 ,2 ]
Prétet J.-L. [1 ,2 ,3 ]
Riethmuller D. [1 ,2 ,3 ]
Chotard M. [2 ,3 ]
Mougin C. [1 ,2 ,3 ]
Mercier M. [1 ,2 ,3 ]
机构
[1] Univ Franche-Comte
[2] EA 3181, FED4234
[3] CHU Besancon
关键词
Epidemiology; Genotyping; HPV infection; Screening; Young females;
D O I
10.1016/j.jegh.2013.11.003
中图分类号
学科分类号
摘要
Investigation of the prevalence and risk factors of human papillomavirus (HPV) infection is the basis for developing prophylactic strategies against cervical cancer, especially for young women. This study aimed to assess the prevalence and risk factors of HPV infection among a cohort of sexually active young French women eligible for catch-up vaccination. Between 1997 and 2007, 2163 women aged 15-23. years attending consultations at the department of gynecology in the Hospital of Besançon (France) were screened for high risk HPV (HR HPV) infection. Risk factors were investigated through a questionnaire sent to all participants in 2010. HPV DNA was detected by HC2 and Probe Set assays. The overall prevalence for HR HPV and HPV16, 18 and/or HPV45 was 44.6% (95% CI, 42.5-46.7%) and 19% (95% CI, 17.3-20.7%), respectively. The response rate to the questionnaire was 22.6%. The prevalence of independent risk factors (age older than 19, smoking, and oral contraception) for HPV 16/18/45 infection in this population was less than 20%. Based on this study, HPV vaccination should be offered not only to teenage girls, but also to young women, regardless of their sexual activity. © 2014 Ministry of Health, Saudi Arabia.
引用
收藏
页码:35 / 43
页数:8
相关论文
共 50 条
  • [11] The Prevalence and Incidence of Oral Human Papillomavirus Infection Among Young Men and Women, Aged 18-30 Years
    Pickard, Robert K. L.
    Xiao, Weihong
    Broutian, Tatevik R.
    He, Xin
    Gillison, Maura L.
    SEXUALLY TRANSMITTED DISEASES, 2012, 39 (07) : 559 - 566
  • [12] Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18-45 years
    Su, Yingying
    Zheng, Tingquan
    Bi, Zhaofeng
    Jia, Xinhua
    Li, Yufei
    Kuang, Xuefeng
    Yang, Yuan
    Chen, Qi
    Lin, Hongyan
    Huang, Yue
    Huang, Shoujie
    Qiao, Youlin
    Wu, Ting
    Zhang, Jun
    Xia, Ningshao
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [13] Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia
    Temesgen, Minwuyelet Maru
    Alemu, Tefera
    Shiferaw, Birtukan
    Legesse, Seid
    Zeru, Taye
    Haile, Mahteme
    Gelanew, Tesfaye
    PLOS ONE, 2021, 16 (03):
  • [14] Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women
    Santos Filho, M. V. C.
    Gurgel, A. P. A. D.
    Lobo, C. D. P.
    Freitas, A. C. F.
    Silva-Neto, J. C.
    Silva, L. A. F.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02):
  • [15] Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine
    Igidbashian, Sarah
    Boveri, Sara
    Bottari, Fabio
    Urbinati, Ailyn Vidal
    Preti, Eleonora
    Casadio, Chiara
    Landoni, Fabio
    Sideri, Mario
    Sandri, Maria Teresa
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2017, 21 (01) : 4 - 8
  • [16] Detection of High-risk Human Papillomavirus Types 16 and 18 but not 33 and 52 in External Genital Warts from Iranian Females
    Jaberipour, Mansooreh
    Momtahan, Mozhdeh
    Najib, Fatemehsadat
    Amooei, Sedigheh
    Saidifard, Farzaneh
    Ghaderi, Abbas
    Habibagahi, Mojtaba
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (03) : 771 - 774
  • [17] Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years
    Einstein, Mark H.
    Baron, Mira
    Levin, Myron J.
    Chatterjee, Archana
    Fox, Bradley
    Scholar, Sofia
    Rosen, Jeffrey
    Chakhtoura, Nahida
    Lebacq, Marie
    van der Most, Robbert
    Moris, Philippe
    Giannini, Sandra L.
    Schuind, Anne
    Datta, Sanjoy K.
    Descamps, Dominique
    HUMAN VACCINES, 2011, 7 (12): : 1359 - 1373
  • [18] Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 1826years
    Yoshikawa, Hiroyuki
    Ebihara, Keiko
    Tanaka, Yoshiyuki
    Noda, Kiichiro
    CANCER SCIENCE, 2013, 104 (04) : 465 - 472
  • [19] Prevalence of high-risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran
    Safaei, Akbar
    Khanlari, Mahsa
    Momtahen, Moghdeh
    Monabati, Ahmad
    Robati, Minoo
    Amooei, Sedigheh
    Valibeigi, Behnaz
    Azarpira, Negar
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (04) : 681 - 685
  • [20] DETERMINATION OF THE DIAGNOSTIC ACCURACY OF TESTING FOR HIGH RISK (HR) HUMAN PAPILLOMAVIRUS (HPV) TYPES 16, 18 AND 45 IN PRECANCEROUS CERVICAL LESIONS
    Tiews, S.
    Steinberg, W.
    Schneider, W.
    Hanrath, C.
    ACTA CYTOLOGICA, 2010, 54 (03) : 485 - 485